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Background: Low back pain (LBP) is a major health issue due to its high prevalence rate and socioeconomic cost.
While spinal manipulation (SM) is recommended for LBP treatment by recently published clinical guidelines, the
underlying therapeutic mechanisms remain unclear. Spinal stiffness is routinely examined and used in clinical decisions
for SM delivery. It has also been explored as a predictor for clinical improvement. Flexion-relaxation phenomenon has
been demonstrated to distinguish between LBP and healthy populations. The primary objective of the current study is
to collect preliminary estimates of variability and effect size for the associations of these two physiological measures
with patient-centered outcomes in chronic LBP patients. Additionally biomechanical characteristics of SM delivery are
collected with the intention to explore the potential dose–response relationship between SM and LBP improvement.
Methods/Design: This is a prospective, observational study applying side-lying, high velocity, low amplitude SM as
treatment for patients with LBP over a course of 6 weeks. Approximately 80 participants will be enrolled if they present
with chronic LBP of 1, 2 or 3 in Quebec Task Force Classification for spinal disorders, a Roland-Morris Disability
Questionnaire (RMDQ) score≥ 6, and persistent LBP≥ 2 with a maximum≥ 4 using numerical rating scale.
Patient-centered outcomes include LBP using visual analog scale, RMDQ, and PROMIS-29. Lumbar spine stiffness is
assessed using palpation, a hand-held instrumented device, and an automated device. Flexion-relaxation is assessed using
surface electromyography at the third level of the lumbar spine. Biomechanical characteristics of SM are assessed using a
self-reported, itemized description system, as well as advanced kinetic measures that will be applied to estimate forces
and moments at the lumbar segment level targeted by SM.
Discussion: Beside alterations in material properties of the passive components of the spine, increased neuromuscular
activity may also contribute to a stiffened spine. Examining changes in both spinal stiffness and flexion-relaxation along
the course of the treatment provides an opportunity to understand if the therapeutic effect of SM is associated with its
action on active and/or passive components of the spine.
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Low back pain (LBP) is a major public health problem due
to its high prevalence and staggering socioeconomic im-
pact [1-5]. The pathophysiology of chronic LBP in particu-
lar is not well understood, with approximately 90% of
cases categorized as either idiopathic or non-specific [6,7].
Conservative approaches for LBP treatment include medi-
cation, exercise, and manual therapy [8]. Spinal manipula-
tion (SM), a form of manual therapy delivered by physical
therapists, osteopathic physicians and most commonly by
doctors of chiropractic (DCs), has been recommended by
recently published clinical practice guidelines as an effect-
ive treatment option for LBP [8,9]. Systematic reviews of
clinical trials demonstrate that SM has therapeutic effects
comparable to other non-invasive treatment methods
such as physical therapy and core muscle exercise [10-13].
In the U.S., at least 8% of the population seeks care
from DCs annually, representing approximately 190 mil-
lion patient visits [14]. Among patients reporting back
or neck pain, 20% seek chiropractic care [15]. Addition-
ally, patients are highly satisfied with chiropractic care
[16,17]. In spite of its relatively widespread use by the
public, the underlying therapeutic mechanisms of SM
are largely unknown. Thus, it is important to investigate
physiological measures that may serve both as markers
of LBP severity and clinical response to SM. Two such
measures are spinal stiffness and the flexion-relaxation
phenomenon.
Manual therapy practitioners routinely assess spinal
stiffness (e.g. the perceived spinal resistance to manually
applied force) as one component of the clinical evaluation
[18]. Combined with information from the overall clinical
picture, DCs may elect to employ SM targeted toward re-
gions of higher resistance with the intention to improve
mobility, which in turn is believed to contribute to im-
proved clinical outcomes [19,20].
Studies show increased spinal stiffness using instru-
mented stiffness measurements in patients with LBP
compared to those who are asymptomatic [21,22]. One
recent study by Fritz et al. [23] suggests that spinal stiff-
ness assessed using an automated device may be a valu-
able predictor of clinical outcome for patients with LBP
[23]. In particular, the authors found an immediate
decrease in spinal stiffness following the first treatment
and lower baseline spinal stiffness were associated with
better Oswestry disability index scores after 1 week of
SM treatment. However, there are conflicting reports
regarding whether or not SM can reduce spinal stiffness
[23-28].
The flexion-relaxation phenomenon (FRP) provides in-
formation regarding the nature of neuromuscular func-
tioning in patients with LBP [29]. It is characterized by
relaxation of lumbar paraspinal muscles during full torso
flexion while standing. The muscular relaxation is likelyassociated with the principle of energy conservation as
passive tissues are thought to support and stabilize the
spine at the end range position without the need for
active muscle contraction [30]. The phenomenon can
readily be seen by visual inspection of a plot of electro-
myographic (EMG) data taken from the lumbar para-
spinal musculature while a participant stands erect,
bends forward as far as he/she can, maintains the fully
flexed position briefly, and then returns to the upright
position. For asymptomatic individuals, the plot typically
shows very little muscular activity while the participant
stands erect, an increase in activity while bending for-
ward due to eccentric paraspinal muscle contraction,
very little activity while fully flexed, and a greater activity
increase while arising due to concentric muscular con-
traction. Several ways of quantifying the FRP have been
reported in the literature, although no one method has
emerged as universally accepted [31,32]. In general,
comparisons have been made between 1) the highest
muscle activity recorded while the participant is bending
forward vs. the mean value while fully flexed, and 2) the
highest muscle activity recorded while extending to an
upright position vs. the mean value while fully flexed.
The phenomenon is most clearly seen in patients with-
out LBP [33]. The absence of or a reduced FRP, indicat-
ing paraspinal muscle activation instead of relaxation
during full torso flexion, is thought to represent neuro-
muscular system dysfunction, and is typical in patients
with LBP [29]. Based on a review of the literature, there
are indications that FRP may be a valuable objective
clinical tool to aid in the diagnosis and treatment of pa-
tients with LBP [34].
Given the above, the primary objective (i.e. Specific Aim
1) of the current study is to collect preliminary estimates
of variability and effect size for the associations of these
two physiological measures with patient-centered out-
comes in patients with chronic LBP. Study findings will aid
us in planning properly-powered clinical trials that exam-
ine if baseline lumbar spine stiffness and flexion-relaxation
1) are associated with baseline patient-centered outcomes;
2) predict improvement in patient-centered outcomes after
treatment with SM; and 3) improve along the course of
treatment.
Secondary objectives (i.e. Specific Aim 2) will explore
the therapeutic mechanism of SM from a dose–response
perspective. We will obtain preliminary estimates of vari-
ability and effect size to determine if differences in spinal
manipulation delivery, as estimated by thrust contact force
and spinal segment load, are related to patient-centered
outcomes. Clinicians use a variety of SM procedures but
most commonly contact the patient with their hands while
delivering quick dynamic loads at specific locations of the
spine with a duration range of 100–500 milliseconds
[35-39]. These quickly applied dynamic forces are known
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considerable variation exists in HVLA-SM in terms of rate
of loading, pre-load, peak force, and duration of loading,
quantification and standardization of delivery may be im-
portant for maximizing therapeutic effects [38,40-42]. In
the current study, DC self-reported descriptions of
HVLA-SM and lumbar spine segmental load estimation
methods have been developed and implemented to ex-
plore this area. Additionally, dynamic spinal stiffness dur-




Ethics approval was obtained from the Palmer College of
Chiropractic Institution Review Board (IRB) with the As-
surance Number - X2011X141. Participants are eligible
if they are between 21–65 years old, meeting the classifi-
cation of 1, 2, or 3 in Quebec Task Force (QTF) classifi-
cation for Spinal Disorders [45,46], present with LBP for
more than 12 weeks, have a Roland Morris Disability
Questionnaire (RMDQ) ≥ 6 at phone screen, and a self-
reported average pain within the past 24 hours ≥ 2 at
phone screen and baseline visits 1 and 2 (BL1 and BL2),
and ≥ 4 at phone screen or BL1 on an 11 point numer-
ical rating scale (NRS). A more detailed description of
the inclusion/exclusion criteria is summarized in Table 1.
Potential participants are recruited using a multimedia
approach of newspaper ads and direct mail promotions
that have been used in our previous LBP studies [47-49].
Additionally press releases, media interviews, a local
newspaper website, community flyers, roadside signs,
Craigslist, and other online classified ads are used. All
advertisement methods involved in the recruitment
process have been approved by the Palmer College of
Chiropractic IRB.
Study design
The current study is a prospective observational trial
to evaluate the delivery of HVLA-SM using patient-
centered outcomes and physiological measures over a
course of 6 weeks. A total of 80 participants are pro-
jected to be recruited over a period of 20 months
(September 2012 through May 2014, roughly 4 partici-
pants per month). Primary outcomes include patient-
centered outcomes of back pain and function and
physiological measures. Physiological measures consist
of posterior-anterior stiffness of the lumbar spine using
three assessment methods and flexion-relaxation. The
assessment for physiological measures is implemented in
the following sequence: lumbar spine stiffness measure-
ments using hand palpation, a hand-held instrumented
stiffness device, an automated stiffness device, and
flexion-relaxation. The sequence was chosen to improvevisit efficiency and reduce participant burden. Secondary
outcomes include the descriptive record of SM delivered
in each treatment visit (TV) and lumbar spine segmental
load during SM delivery. Demographic and clinical char-
acteristics of the participants are collected during BL1.
Patient visit protocol
Participant screening begins with an initial eligibility de-
termination via phone screen. Interested and eligible
participants are scheduled for an in-person BL1 consist-
ing of an informed consent process and comprehensive
clinical examination. Following the BL1 a panel ren-
ders eligibility decisions for criteria requiring clinical
decision-making in a process called case review, as de-
scribed in more details below. Final eligibility determin-
ation and enrollment for participants still eligible occurs
during BL2. The treatment phase consists of 2 TVs per
week over an approximate 6 week period. The BL2 (pre
enrollment) and TV1 (post enrollment) occur on the
same day. Patient-centered outcomes are collected at
BL1, TV6, and TV13. The physiological assessments are
performed immediately before and after SM delivery
during TV1, TV5, and TV12 (6 sets of assessments in
total). During these same TVs, full kinetic measures dur-
ing SM delivery are captured for lumbar spine segmental
load analysis. SM thrust profiles (i.e. simple kinetics in-
cluding contact force and displacement and acceleration
at DC’s thrusting hand) are assessed separately at TV3
and TV9. An exit interview occurs at the 13th TV fol-
lowing the completion of treatment and all study related
activities. The detailed visit-by-visit activities are summa-
rized in Table 2.
Eligibility determination
Interested individuals contact our center by phone or
with a return pre-stamped postcard. Study personnel ad-
minister a short computer-assisted telephone interview
to screen for provisional eligibility and, if eligible and
still interested, schedule a BL1 visit. During a BL1visit, a
study coordinator reviews the informed consent docu-
ment, study flow chart, and specific visit activities with
the participant. A short video describing study proce-
dures is also viewed. The participant has opportunity to
read the informed consent document and ask questions.
Those who wish to further participate sign the written
informed consent document. Vital signs, height, and
weight are then measured by a study coordinator and
the participant completes several research forms includ-
ing patient-centered outcomes, demographics, Beck
Depression Inventory, a substance assessment question-
naire, medication use, and a health history. Study coor-
dinators review forms for incomplete data and answer
computer-based questions programmed with eligibility
criteria.
Table 1 Study inclusion and exclusion criteria
Inclusion criteria Rationale Source
Age≥ 21 and≤ 65 Chronic LBP not as common under age 21. Older adults not as likely to tolerate
biomechanical tests
PS, BL1
Chronic low back pain matching QTF Classifications 1, 2,
and 3
Low back pain, uncomplicated by known nerve root compression, neurological
signs or prior surgery
CR
RMDQ≥ 6 Disability high enough to prevent floor effect PS
NRS Pain (Average within past 24 hours)≥ 2 at PS and
BL1 and BL2, and≥ 4 at PS or BL1




Additional diagnostic tests or urgent/emergent
procedures needed beyond study exam procedures
Advanced diagnostic tests or other necessary evaluation(s) are outside study
scope
CR
BMI≥ 40 Unable to adequately perform manipulation procedures per study protocol BL1
BDI II score≥ 29 May interfere with protocol compliance and data collection BL1
Compliance concerns May compromise ability to comply with study protocols CR
Co-morbidity requiring coincident clinical management May interfere with study requirements, pose significant scheduling burden, or
pose a safety risk
CR
Inability to read or verbally comprehend English Proxy unavailable BL1
Inflammatory or destructive tissue changes to the spine Potential intolerance to biomechanical testing or treatment protocols PS, CR
Joint replacement history Potential intolerance to biomechanical testing or treatment protocols PS, CR
Moving from area within 8 weeks May interfere with ability to comply with study protocol PS,
BL1,
BL2
Neuromuscular disease Interference with biomechanical measurements PS
No indication for SM at L1 – L5 or sacroiliac joint (s) Spinal Manipulation is only treatment available CR
Open or pending litigation for LBP or seeking/receiving
disability compensation
May interfere with study compliance or data collection PS, BL1
Pacemaker/Defibrillator Safety due to potential electromagnetic fields produced by biomechanical testing
equipment
PS, BL1
Peripheral arterial disease Potential intolerance to biomechanical tests, potential need for referral, and
interference with pain and disability measures
PS, CR
Pregnancy Safety for biomechanical testing and may interfere with data collection PS, BL1
QTF classification 4-11 Conditions sufficiently complicated to cause intolerance to biomechanical testing
procedures or data collection
CR
Received SM within past 4 weeks May interfere with data interpretation BL1
Safety Precaution for condition(s) posing a safety risk or intolerance for treatment or
biomechanical tests (i.e., excessive bruising/bleeding and adhesive sensitivity)
CR
Suspicion of drug or alcohol abuse May interfere with data collection, ability to comply with study protocol, and
require referral
CR
Uncontrolled hypertension May interfere with study protocols and require referral CR
BDI-II: Beck Depression Inventory; BL1: Baseline Visit 1; BL2: Baseline Visit 2; BMI: body mass index; CR: Case Review; L1 – L5: lumbar segment level 1 to 5. LBP: low
back pain; NRS: numerical rating scale; PS: Phone Screen; QTF- Quebec Task Force; SM: Spinal Manipulation.
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ing where further information is needed to determine
eligibility. The DC then conducts a focused low back
diagnostic examination by first obtaining a focused LBP
history. Lumbar spine X-rays and/or urinalysis may be
obtained to assist in diagnosis and provide information
to render a safety determination. If additional laboratory
procedures or diagnostic tests are required to evaluate
the participant’s LBP or health status, he or she isexcluded and referred to an appropriate healthcare pro-
vider. With participant consent, other health records
may be requested and reviewed to determine eligibility.
Following the BL1, participants are scheduled for the
BL2.
The clinician who performed the BL1 examination
presents findings to a Case Review panel consisting of
research clinicians, study coordinators, and at least one
investigator. The Case Review panel renders eligibility
Table 2 Summary of clinical activities in the visit-by-visit
basis
Visit Activities
Screening Phone screen Computer‐assisted
telephone interview







Demographics & Vital signs
Examination
X-ray & Urinalysis, if indicated
Case review
Baseline visit 2 Report of findings, enroll




Post-treatment pain in VAS
Treatment visit 2 Pre-treatment pain in VAS
Treatment
Post-treatment pain in VAS
Treatment visit 3 Pre-treatment pain in VAS
Treatment-simple kinetics
Post-treatment pain in VAS
Treatment visit 4 Same as treatment visit 2
Treatment visit 5 Same as treatment visit 1
Treatment visit 6 Patient-centered outcomes
Pre-treatment pain in VAS
Treatment
Post-treatment pain in VAS
Treatment visits 7-8 Same as treatment visit 2
Treatment visit 9 Same as treatment visit 3
Treatment visits 10-11 Same as treatment visit 2
Treatment visit 12 Same as treatment visit 1
Exit interview Treatment visit 13 (Final) Patient-centered outcomes
Satisfaction questionnaire
Exit interview
HIPAA: Health Insurance Portability and Accountability Act; VAS: visual
analog scale.
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ical decision-making. Case Review provides a formally
structured eligibility determination process including at
least 1 person from each of 3 roles: the consentingcoordinator, research clinician, and investigator to: 1) fa-
cilitate consistent interpretation of eligibility criteria; 2)
ensure participant safety; and 3) mitigate selection bias.
This research team has used a similar case review
process to determine eligibility in previous clinical trials
[47,49]. Following eligibility determination, a web mod-
ule programmed with explicit exclusion criteria is com-
pleted for each participant. Eligible participants proceed
to the BL2. Participants no longer eligible receive a
phone call from the examining clinician who informs
them of the determination, a summary of the exam find-
ings and appropriate clinical recommendations.
Spinal manipulation intervention
A standardized side lying, HVLA-SM is the treatment
procedure utilized. Participants lie in a lateral recumbent
position with the lower leg straightened and the superior
or free leg flexed at both the hip and knee and adducted
across midline. The DC, standing and facing the partici-
pant, stabilizes the superior shoulder or upper arm with
one hand (i.e. non-thrusting hand) as the participant’s
forearms rest across the chest or abdomen. The partici-
pant’s free leg is stabilized by the DC’s thigh or lower leg
(i.e. contacting leg, the same side as the thrusting hand).
The manipulative load is delivered by a quick, and short
controlled movement of the DC’s shoulder, arm, and
hand in combination with a slight body drop. The areas
where the thrusting hand contacts the participant in-
clude lumbo-pelvic tissues over or adjacent to vertebral
mammillary and spinous processes, between and slightly
lateral to the posterior superior iliac spine of the ilium,
ischial tuberosity, and the sacrum. The manipulative
load is also transmitted to participants through the clini-
cian’s stabilizing thigh/leg, resulting in a twisting force
directed to the pelvis. In the current study the thrust is
only delivered using the palmar aspect of the hand.
Other side lying HVLA-SM procedures utilizing other
manual contacts, such as pulling on a lumbar spinous
process with fingers, are not utilized. The HVLA-SM is
delivered by a team of trained and experienced clinicians
who have at least 15 years of clinical experience using
HVLA-SM for treating patients with LBP. To enable the
assessment of segmental load at the lumbosacral region
during the TV1, TV5, and TV12, the patient’s upper
body is restrained by an external strap system while the
clinician places the non-thrusting hand on a rest located
near the participant’s free shoulder [50,51].
Primary outcome measures
Patient-centered outcomes
The primary patient-centered outcomes include the Vis-
ual Analog Scale (VAS) for LBP, the 24-item RMDQ,
and the Patient Reported Outcomes Measurement Infor-
mation System (PROMIS)-29 questionnaire. The RMDQ
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LBP and is more responsive to change over time than
most other functional status measures [52-54]. The VAS
is used to evaluate the worst, least, and average LBP over
the past 24 hours using a 100 millimeter horizontal scale
(0 = no pain; 100 = worst imaginable pain). Current pain
is also monitored with the VAS at the beginning and end
of each TV. The VAS has excellent metric properties, is
easy to administer and score, and has received much use
in LBP research [11]. The comprehensive LBP status is
evaluated using the PROMIS-29 questionnaire, which is
a collection of questions measuring physical function,
anxiety, depression, fatigue, sleep disturbance, satisfac-
tion with social role, pain interference and pain intensity.
It aims to provide clinicians and researchers access to ef-
ficient, precise, valid, and responsive adult- and child-
reported measures of health and well-being [55]. Bio-
mechanical assessors and treating clinicians are blinded
to patient-centered outcomes data.
Posterior-anterior stiffness of the lumbar spine
Lumbar spine stiffness is assessed sequentially with three
approaches using hand palpation, a hand-held instru-
mented device, and an automated device, respectively.
The hand-held instrument approach is the primary meas-
ure as it has been validated by our study team and demon-
strated good reliability (0.79) [56,57]. The same set-up
allows us to implement hand palpation in a manner that
mimics spinal stiffness assessments in clinical practice and
will allow us to explore the association between stiffness
as measured by palpation versus the hand-held instru-
ment. Because the hand palpation approach was thought
to be less intrusive, it is tested before the hand-held ap-
proach in the trial. As we finalized the protocol for study
launch, a study using an automated stiffness assessment
method with high within- and between-day reliabilities
(0.99 and 0.98) was published and suggests that spinal
stiffness may have important clinical implications [23].
We contacted the authors who loaned us the equipment
for use as an added stiffness measure. However, due to the
study timeline, and technical and training requirements,
the automated stiffness procedure was not implemented
until the clinical trial enrolled 20 participants.
During stiffness assessments, participants lie prone
while study clinicians mark the skin with a sterile surgical
marking pen at the following locations: posterior superior
iliac spines, spinous processes the seventh cervical verte-
bra (C7), the eleventh thoracic vertebra (T11) to the fifth
lumbar vertebra (L5), interspinous spaces from T10 to the
first level of sacrum (S1), and the most concave lumbar
segment while lying prone (Figure 1A). During the hand
palpation assessment, the participants lie face down on a
custom-made chiropractic treatment table with force
plates (Model 4060-NC, Bertec Inc., Columbus, OH)embedded under the cushions that support the thoracic
and pelvic regions and acquire the palpatory force trans-
mitted through the participant. The clinician applies a
gentle anteriorly directed force consistent with the level
typically used during examination to the vertebral levels
L1 to L5. An infrared smart marker (Optotrak 3020/Cer-
tus hybrid system, Northern Digital Inc., Waterloo, On-
tario, Canada) is placed on the clinician’s palpatory hand
to simultaneously acquire displacement. The sampling
rate for the Optotrak system is set at 100 Hz while the
sampling rate for the force plates is set at 1000 Hz. No
specific instruction is given to participants in terms of
their breathing during the test. Figure 1B demonstrates
the setup for the palpatory stiffness measurement.
The hand-held stiffness device consists of a force trans-
ducer (Model # LC201-50, Omegadyne Inc., Sunbury,
OH) and infrared smart markers for accurate force and
displacement measurement. The assessment is performed
with the participant lying prone on the treatment table.
The examiner assesses tolerance of participants by press-
ing gradually up to a maximum of 80 N with the stiffness
device in an anterior direction over the pre-marked
spinous process of each lumbar vertebra from L1-L5. Par-
ticipants inform the examiner if the pressure causes dis-
comfort. When the maximum pressure of 80 N is reached
an audible tone sounds as feedback to the examiner to
stop compressing and withdraw the device. If pressure
from the stiffness device causes discomfort, the test is re-
applied more slowly and the participant indicates the level
of pressure causing discomfort. If the tolerance test does
not cause discomfort with 80 N of pressure at any verte-
bral level, the subsequent stiffness tests are conducted
with a maximum pressure of 80 N. If the participant indi-
cates discomfort during the tolerance test, the subsequent
stiffness test is conducted at all vertebral levels using a
maximum force value 10 N lower than the lowest value
causing discomfort at any vertebral level during the toler-
ance test. If tolerance to the hand-held stiffness device is
less than 60 N at any vertebral level, the hand-held stiff-
ness test, as well as the automated stiffness test, is not per-
formed. Both force and displacement are recorded using a
Motion Monitor data acquisition workstation (Innovative
Sport Training, Chicago, IL) at a sampling rate of
1000 Hz. The stiffness measures are performed by press-
ing anteriorly over each lumbar spinous process for 5 cy-
cles at a rate of approximately 1 repetition per second.
The participants are instructed to make a deep breath in,
a deep breath out, and then inhale half way and hold their
breath during which the test is performed. The average
stiffness obtained over the last 4 cycles is used for analysis.
Figure 1C demonstrates the setup for the hand-held stiff-
ness measurement.
The automated stiffness test consists of 1) a height-
adjustable treatment table equipped with safety switches
Figure 1 Illustration of spinal stiffness assessment tests. Skin marks over bony landmarks of the T11-L5 spinous processes and posterior
superior iliac spine (A), palpatory stiffness assessment (B), stiffness assessment with a hand-held device (C); and stiffness assessment with an
automated device (D).
Xia et al. BMC Complementary and Alternative Medicine 2014, 14:292 Page 7 of 15
http://www.biomedcentral.com/1472-6882/14/292to allow either the participant or examiner to immedi-
ately lower the table thereby withdrawing from the auto-
mated stiffness device; 2) an automated stiffness device
that extends and applies a designated force; and 3) a
computer system to program device movement based on
displacement/force data sent from the device in real-
time using a custom-written program in LabVIEW with
a sampling rate at 200Hz (Version 8, National Instru-
ments Corp., Austin, TX) [23,58,59]. The automated
stiffness device is positioned over the spinous process
nearest the most concave point of the lumbar curve
while in the prone position, typically corresponding with
the L3 spinous process. When the lumbar spine is not
concave in shape (e.g. flat or convex lumbar spine) or
the L2 or L4 level appears to be at similar height as L3,
the automated stiffness device is placed over the L3
spinous process. Participants are instructed to lay prone,
inhale then exhale normally, and hold their breath at the
end of exhalation for approximately 10 seconds during
which the automated stiffness test is performed. During
the test, the actuator on the automated device advances
at a rate of 2.5 mm per second. After reaching a preload
force of 5 N on the target spinous process, the actuator
holds the preload for one second before advancing fur-
ther and applying a maximum load of 60 N. The max-
imum load is maintained for one second before the
actuator retracts. To decrease participant’s burden in
holding the breath, the initial position of the actuator is
placed as close as possible to the target spinous processas long as the participants can breathe normally without
pushing against the actuator. The procedure is con-
ducted three times during each assessment with a testing
trial performed prior to data collection to orient the par-
ticipant to the procedure and to determine safety. The
average stiffness of the three trials is used for analysis.
Figure 1D demonstrates the setup for the automated
stiffness measurement.
Data reduction: For all three stiffness measurement
tests, force and displacement data are acquired simultan-
eously. Data acquired from the hand palpation and hand-
held stiffness tests are exported into a custom-written
MATLAB program (MathWorks Inc., Natick, MA) and
the graphs of displacement against force are plotted. The
user identifies the points corresponding to 10 N and 60 N
and the software computes the slope of the curve within
the region using linear regression. For the automated stiff-
ness test, the LabVIEW program is used to compute stiff-
ness using the same algorithm as that of the MATLAB
program. It is worth noting that spinal stiffness obtained
in vivo in the current study is different from the inter-
segmental stiffness typically obtained in specimen studies.
To distinguish between them, the term global stiffness
was suggested to describe the stiffness measurement over
a region of the spine containing several segments [60].
Consultation with DCs performing treatments in this
study revealed that relative perceived stiffness as opposed
to the absolute stiffness of a given spinal segment provides
the most useful clinical information. Therefore, to be
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DCs the global stiffness variation (GSV) is calculated as:
GSV ¼ max gs1;gs2;gs3;gs4;gs5ð Þ−min gs1;gs2;gs3;gs4;gs5ð Þ
where gsi is the global stiffness measured at the lumbar
spine and i = 1,2,…,5.
To account for the between-subject variation in the
global stiffness measurement (e.g. a participant may have
an overall stiffer or more flexible lumbar spine), the nor-
malized GSV (nGSV) is calculated as:
nGSV¼ GSV
mean gs1;gs2;gs3;gs4;gs5ð Þ
Both GSV and nGSV are obtained from the palpatory
and hand-held stiffness tests and will be used in data
analysis.
Flexion-relaxation phenomenon
Surface EMG measurements of lumbar paraspinal muscle
activity for FRP analysis in this study were initially taken
with a system using Ag/AgCl electrodes built into a plastic
enclosure along with a solid state preamplifier (Therapeu-
tics Unlimited model 544, Iowa City, IA – no longer in
business). Motion data were initially taken with an elec-
tronic goniometer (SG150B, Biometrics Ltd, Newport,
UK) that was synchronized with the EMG system. After
the first 30 participants, both measurement systems were
replaced with a wireless EMG system with integrated ac-
celerometers to provide motion data (Delsys Inc. Trigno
Wireless System, Natick, MA). The major difference be-
tween the two EMG systems is that the original system
had fixed-distance electrodes, whereas the current Delsys
system uses two separate electrodes. The EMG and mo-
tion data are recorded using the Motion Monitor work-
station with a sampling rate of 1000 Hz.
FRP measurements take place pre and post treatment
during TV1, TV5, and TV12. The skin over the lumbar
paraspinal muscles is prepared by vigorously rubbing the
skin with an alcohol wipe. The participant, seated on a
stool, leans forward while disposable, self-adhesive, pre-
gelled surface EMG Ag/AgCl snap electrodes (Dispos-
able ECG electrode white foam type, 36 mm in diameter,
AMBU Inc., Copenhagen, Denmark) are placed on the
skin over the mid-lumbar paraspinal muscles (Figure 2).
Specifically the electrodes are placed with one above and
one below the L3 level on each side with approximately
1 cm vertical distance between the edges of the elec-
trodes in a semi-flexed position such that when the par-
ticipant sits erect, the electrodes do not touch. Because
the electrodes are removed to enable HVLA-SM, the
outline of each electrode is drawn with a skin marking
pen so new ones can be placed in the same location for
the post treatment measurements.Participants are instructed to place their feet shoulder
width apart with their arms hanging loosely at their side.
Keeping their knees straight, they bend forward as far as
they can and hold that position for 3 seconds, then re-
turn to the upright standing position. Participants per-
form this movement once as practice and to allow
research personnel to ensure proper functioning of the
system. The participant then performs the procedure 3
times in a continuous manner while the EMG and mo-
tion data are collected.
Data reduction: In order to quantify the degree to
which the FRP is present, two different forms of a
flexion-relaxation ratio (FRR) are used [31,32]. One is
calculated by dividing the maximum root mean square
(RMS) EMG activity level during flexion (while bending
forward) by the lowest mean EMG activity as measured
over a one second interval during the fully flexed phase.
Another FRR is similarly calculated by dividing the max-
imum RMS EMG activity level during extension (while
returning to standing erect) by the same minimum. The
beginning and end of the fully flexed phase for each
cycle are determined from the plot of the motion data.
A macro written in Visual Basic for Applications, within
Microsoft Excel (Microsoft Corp., Redmond, WA), is
used to identify the specific regions of the data plots.
These are regions of full flexion, the regions in which
the trunk is flexing forward, and the regions in which
the trunk is extending while returning to the upright
position. The macro allows the user to adjust the limits
of the various regions of the plot in order to exclude oc-
casional spurious spikes in the RMS EMG data.
In all, 12 FRRs are calculated each time the participant
performs this test. A set of 3 FRRs is based on the max-
imum RMS EMG activity during flexion – 1 FRR for each
of the 3 cycles from the left paraspinal muscles. Another
set of 3 is made from the right paraspinal muscles. Simi-
larly, 2 more sets of 3 are made: one based on the max-
imum RMS EMG activity levels during extension from the
left and the other similarly from the right paraspinal mus-
cles. The FRRs for the 3 cycles of each situation are aver-
aged which yields 4 mean FRRs each time a participant
performs this activity: a mean FRR from flexion and one
from extension for the left and right side. Once the re-
gions have been identified the macro performs the neces-
sary calculations.Secondary outcome measures
DC self-reported record of SM delivery over the course of
treatment
DCs report all HVLA-SM delivered using a record log
as illustrated in Figure 3. This information will allow us
to better identify SM delivery patterns from the clinical
perspective.
Figure 2 Illustration of EMG electrode placement (A) and example EMG and motion signals (B). Root-mean-square (RMS) EMG data and
motion data are scaled according to the maximum of RMS EMG data (B). B contains 3 cycles of flexion (B1), holding in position while fully flexed
(B2), and extension (B3).
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The measurement of contact force characteristics occurs
as a part of the dynamic stiffness assessment (see more
details below). The data reduction program used for seg-
mental load is applied to extract variables from the con-
tact force as measured under the clinician’s thrusting
hand. These variables include the force exerted during
the preload phase before the HVLA thrust, the loading
rate, and peak force.
Segmental load
The method for estimating lumbar spine segmental load
proposed by Triano and Schultz [50] and Triano et al.
[51] was adapted for use in the current study with twomodifications. Rather than using a rigid chest panel to
limit the participant’s upper body movement, we
stabilize the upper shoulder with a shoulder strap
crossed behind the participant (Figure 4). The strap
restricts the predominant motion of the participants re-
ceiving HVLA-SM, which tends to include whole-body
movement in the cephalic direction and a rolling move-
ment of the lower trunk toward the clinician. The strap
design attempts to mimic the clinician’s stabilization
hand (non-thrusting hand). The strap is then secured to
the force plate right under the participant’s thoracic cage
such that force and moment occurring during the
HVLA-SM procedure are monitored. The clinician’s
non-thrusting hand is placed on a moveable rest located
Figure 3 Self-reported record for high velocity, low amplitude spinal manipulation. Level: the segment over which the manual contact
occurs (L1-5, sacrum, and sacroiliac joint); Side Up: side of body contacted by clinician providing trunk twist motion direction; Contact Point:
manual contact of the thrusting hand; SP: spinous process; MP: mammillary process; DW: interspinous space 1 cm lateral to spinous processes;
PSIS: posterior superior iliac spine; Ischial Tubes: Ischial tuberosity; Fossa: midpoint between ischial tuberosity and PSIS; Base: Medial aspect of the
superior sacrum; Apex: inferior sacrum; Ala: sacral ala or lateral superior sacrum; Direction of thrust: direction of thrust applied by the thrusting
hand; A: anterior; S: superior; I: inferior; M: medial; L: lateral.
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proximate the typical position attained during the pro-
cedure and to help the clinician maintain balance
(Figure 4). The location of the lumbar segment targeted
by the contact hand is traced with three Optotrak smart
marker rigid bodies during the HVLA-SM procedure in-
stead of the one-time digitization during the preload
phase used by Triano et al. [51]. As a result, it is possible
to compensate for the effect that lumbar spine move-
ment may have on segmental load.
The method described in Triano and Schultz [50] and
Triano et al. [51], however, does not consider the effect
of lumbar segment orientation on segmental load. As a
result, only the magnitude of the segmental force and
moment will be reported. To estimate three-
dimensional segmental load, the location of the joint
center and its orientation of the target lumbar segmentFigure 4 Illustration of segmental load assessment during side-lyingneed to be determined. We adopted the method devel-
oped by Splittstoesser [61] to fulfill this task. The pro-
cedure involves the creation of individualized lumbar
spine models in the standing posture using skin marks
over key spinal landmarks [62]. Additionally four Opto-
trak smart marker rigid bodies are placed at C7, T7,
T10, and S1 to estimate the orientation of the target
segment using the individualized lumbar spine model
(Figure 4) [61]. The limitation of Splittstoesser’s method
is that it is only designed to estimate sagittal plane mo-
tion. It does not account for lumbar spine axial rotation
or lateral flexion, which may also occur during HVLA-
SM. Thus, investigation of the effects of segment orien-
tation on segmental load estimation in this study is
exploratory.
Data reduction: A custom-written MATLAB program
is applied for segmental load data reduction. Variableshigh-velocity spinal manipulation.
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and moment during the preload phase of the HVLA-
SM, loading rate, and peak force and moment.
Dynamic stiffness
To investigate dynamic spinal stiffness (i.e. the displace-
ment, acceleration and force characteristics in time), a
mixed approach is applied to measure: the movement of
the doctor’s thrusting hand using a triaxial accelerom-
eter (Model 356A17, PCB Piezotronics Inc., Depew,
NY) with a sampling rate at 1000 Hz; the Optotrak mo-
tion capture system with a sampling rate at 100 Hz; and
the arithmetic summation of the thrusting force over
the area at the base of the palm using a thin pressure
pad (Pliance system, Novel Electronics, St Paul, MN)
with a sampling rate of 50 Hz. Our previous study dem-
onstrated that a sampling rate at 50 Hz is sufficient for
acquiring contact force during HVLA-SM [36]. Two
characteristics of dynamic spinal stiffness are computed
using the force/displacement/acceleration-time profiles:
1) apparent mass (M) that takes into account the force
applied (F) and the resulting acceleration (a) of the con-
tact interface (M = F/a); and 2) driving-point mechanical
impedance (Z) that takes into account the force applied
(F) and the resulting velocity (v) of the contact interface
(Z = F/v). The dynamic spinal stiffness measures are ob-
tained during TV3 and TV9.
Data collection, management and quality control
A customized submission, tracking and reporting web-
based system was developed for the study. It is com-
prised of multiple sub-modules integrated into one
comprehensive study management web application that
includes sub-modules for computer assisted telephone
interviewing, participant eligibility checking, participant
tracking and report generation. The ASP. NET
web application elements were programmed in C#
and Structured Query Language (SQL) using Micro-
soft Visual Studio 2010 (Microsoft, Redmond, WA,
USA) and Microsoft SQL Server Management Studio.
User-friendly data entry interfaces were programmed
with appropriate participant flow restrictions, validation
schemes and skip patterns. The system uses a Project/
Users Permissions System to control project personnel
access to web modules. The web system is password-
protected and uses a Microsoft SQL Server database
platform to store all data.
Information is collected at every stage of recruitment,
and throughout treatment and assessment so that the pa-
tient flow can be reported according to the Consolidated
Standards of Reporting Trials guidelines [63]. We collect
recruitment source, total number of responses per recruit-
ment source, the resolution of these responses (ineligible,
refused or enrolled), the number of withdrawals and reasonfor withdrawal, and the number of participants completing
the study. For each enrolled participant, we track compli-
ance to the treatment protocol and the assessment data
that were collected at each visit.
Participant self-report questionnaires and clinician-
reported SM delivery records are paper-based forms with
unique participant identification numbers. Study coordi-
nators have oversight for all paper data collection forms,
log each completed form into a form tracking interface of
the web system and submit data forms for key-entry
weekly. These forms are double key-entered by trained
data entry clerks in an MS Windows program using range
and validation checks to improve accuracy and are stored
in locked filing cabinets. The electronic biomechanical
data are stored on a password protected network file ser-
ver. Data reduction is completed within 2 weeks of data
collection, transferred to the data manager in Microsoft
Excel workbooks, and then uploaded to Microsoft SQL
Server and stored with all other project-related data.
Data management and quality control of all data are
performed using SQL views, stored procedures and real-
time, web-based reports. Automated reports are viewed
by the data manager to determine if quality improvement
actions must occur, such as improved documentation,
protocol revisions or personnel retraining. Final project
datasets of combined web, paper and biomechanical data
are assembled by transferring data from Microsoft SQL
Server to SAS System for Windows (Release 9.3, SAS In-
stitute Inc., Cary, NC, USA). Back-up tapes of the network
drive are produced nightly.Protection of human subjects and assessment of safety
Protection of human subjects
The study protocol was approved by the Palmer College
of Chiropractic IRB.Data and Safety Monitoring Committee (DSMC)
This trial is being monitored by an independent DSMC
comprised of epidemiologists with expertise in LBP and
CAM clinical trials, a biostatistician and a doctor of
chiropractic. The DSMC’s role is to provide scientific
and ethical oversight by evaluating the following data
provided to them on a semi-annual basis: participant
recruitment, accrual, and retention; adverse events
(AEs); protocol deviations; data monitoring; and partici-
pant characteristics. To further monitor participant
safety, serious AEs are reported to the chair of the
DSMC within 5 business days. The DSMC makes rec-
ommendations to the Principal Investigator and the Of-
fice of Clinical and Regulatory Affairs at the National
Center for Complementary and Alternative Medicine
regarding continuation, termination, or other modifica-
tions to the study.
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An IRB-approved AE grading and reporting protocol de-
fines the process by which AEs are monitored and catego-
rized for this study. This protocol also outlines when and
how participant safety concerns are reported to the IRB,
DSMC and funding agency. An AE is any untoward med-
ical occurrence that may present itself during the conduct
of the study and which may or may not have a causal rela-
tionship with the study procedures [64]. A serious AE is
defined as any adverse event resulting in any of the follow-
ing outcomes: death, a life-threatening adverse experience,
hospitalization or prolongation of existing hospitalization,
a persistent or significant disability/incapacity, or a con-
genital anomaly/birth defect resulting from a pregnancy.
Participants are asked about adverse experiences at each
TV and instructed to contact study personnel if they ex-
perience significant pain, discomfort or distress that they
believe may be associated with treatment.
Statistical analysis
SAS System for Windows and R (http://www.r-project.org/)
will be used for data analysis. Descriptive statistics of par-
ticipant baseline characteristics and all measurements for
each of the 3 assessment times will be calculated. The 3 dif-
ferent methods of collecting spinal stiffness will be com-
pared with intraclass correlation coefficients. The general
approach to data analysis will be to first summarize the var-
iations in the physiological and kinetic measures using hier-
archical linear regression models and then to use that
information to determine the most appropriate statistical
methods, including linear mixed regression models [65]
and conditional linear mixed regression models [65,66].
For Specific Aim 1, the variations in physiological mea-
sures will be summarized using a hierarchical linear re-
gression model with a random effect for participant. If
there is a non-significant random effect for participant,
then this estimated random effect will be considered aA B
Figure 5 Putative effects of low back pain (A) and spinal manipulatiosufficient summary of the physiological measures over
time and linear mixed regression models will be used to
examine the association between that random effect and
the patient-centered outcome variables. If there is a sig-
nificant random effect for participant, then there is vari-
ation in the measures over time. In this case, a linear
mixed regression model with time-varying covariates will
be fit to assess the association between the physiological
measurements at a particular time point and patient-
centered outcomes at the subsequent visit(s).
For Specific Aim 2, the variations in kinetic measures
will be summarized using a hierarchical linear regres-
sion model with random effects for clinician and for
participant nested within clinician. Intraclass correl-
ation coefficients will be computed to establish if there
is substantial consistency within clinician within partici-
pants and within clinician across participants and if
there is sufficient variation between clinicians to allow
evaluation of how variations in kinetic measures can
predict patient-centered outcomes. If the random effect
for participant within clinician is non-significant, or the
intraclass correlation coefficient is 0.7 or higher, then
the estimated random effect for clinician will be consid-
ered a sufficient summary of the delivery of care by an
individual clinician. In this case, the association between
this random effect and patient-centered outcomes will
be evaluated using a linear mixed regression model. If
there is not sufficient consistency within clinician be-
tween patients, but there is consistency within a clin-
ician within participants, it will indicate that clinicians
vary their care by participant but provide a consistent
level of care across the course of treatment. In this case,
the linear mixed regression model will be used to esti-
mate the association between random effects specific
to the clinician/participant combination and patient-
centered outcomes. If consistency within clinicians and
within participants cannot be established, this indicatesn (B).
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by clinicians within a participant. In this case, we
will fit a linear mixed regression model with time-
varying covariates to assess the association between the
kinetic measurements at a particular time point and
patient-centered outcomes at the subsequent visit(s).
In the analysis for both specific aims 1 and 2, the com-
plexity introduced by modeling with time-varying covari-
ates may be better served with conditional linear mixed
models. Regardless of what model is chosen, alternative
models will be fit to assess the sensitivity of the statistical
model to any assumptions about consistency.
Sample size
A minimum of 80 participants will be enrolled in the
current study. The sample size should be sufficient to
obtain preliminary estimates of variability and effect size
through our planned data analysis, taking into consider-
ation the possibility of dropouts and technical issues that
may occur given the rigor and complexity of this study
protocol.
Discussion
The primary objective of the current study is to examine
the predictive value of spinal stiffness and FRP for patient-
centered outcomes in those with chronic LBP and treated
with HVLA-SM. However, it also allows us to examine
two domains that may contribute to the therapeutic ef-
fects of SM (i.e. neurophysiological and biomechanical
processes). Analyzing both spinal stiffness and FRP mea-
sures in LBP patients undergoing SM treatment may help
elucidate the contributions of passive (skeletal, ligament-
ous and disc structures) and active (muscles) structures
during and following HVLA-SM, thus providing evidence
for suspected therapeutic mechanisms [67].
We hypothesize that changes in lumbar spine stiffness
may be in part attributed to material changes in spinal
tissues and altered paraspinal muscle activity induced
by SM. Figure 5 illustrates two potential mechanistic
pathways (biomechanical and neurophysiological) that are
shared as putative mechanisms of LBP, whereby SM may
lead to altered spinal stiffness and flexion-relaxation
phenomenon in LBP patients. Knowledge gained from this
study will further our understanding of the neuro-
biomechanical mechanisms influenced by SM and may
provide objective assessment measures for use in future
clinical trials.
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